Response to Letter to the Editor From Kawaguchi: "Cardiovascular Safety of Romosozumab vs PTH Analogs for Osteoporosis Treatment: A Propensity Score Matched Cohort Study"

Joshua Stokar*, Auryan Szalat

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

1 Scopus citations
Original languageEnglish
Pages (from-to)e1978-e1979
JournalJournal of Clinical Endocrinology and Metabolism
Volume109
Issue number10
DOIs
StatePublished - 1 Oct 2024

Cite this